OssDsign Hits Commercial Milestone in France

OssDsign Cranial PSI

OssDsign reached the commercial milestone of 200 implants in France since entering the market in late 2019.

In 2019, the French health authorities granted product reimbursement for the OssDsign Cranial PSI implant. During the following years, OssDsign established an initial sales presence, secured first sales and later gained broader market...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0